1. Home
  2. News
  3. Wockhardt Limited
  4. Wockhardt Limited Press Release Aug 10 2026
More Wockhardt Limited news
Wockhardt LimitedNSE: WOCKPHARMA

Wockhardt Limited Press Release Aug 10 2026

Aug 10, 2026 at 8:41 AM EDT · Issued by Wockhardt Limited via NSE India

Filed with NSE · Aug 10, 2026 at 8:41 AM EDT · 3 pages · English

On 6ix: 6ix.com/news/wockhardt-limited-press-release-aug-10-2026

Release

Wockhardt Limited has informed the Exchange regarding a press release dated August 10, 2026, titled Wockhardt Antibiotic Academy, an initiative for Patient-Centric Scientific Dialogue to Tackle Multidrug Resistance .

Wockhardt Limited on 6ix

Earlier from Wockhardt

  • Wockhardt Receives U.S. FDA Approval for ZAYNICH™ (cefepime and zidebactam), a Novel Intravenous Antibiotic for the Treatment of Adult Patients with Complicated Urinary Tract Infection Including PyelonephritisJun 1
  • Press Release May 30 2026May 30
  • Press Release May 28 2026May 27
  • Press Release May 04 2026May 4
  • Press Release Mar 30 2026Mar 30

Later from Wockhardt

  • Wockhardt Limited has informed the Exchange regarding a press release dated November 02, 2026, titled "Pursuant to Regulation 30 of the Listing Regulations, please find enclosed Press Release on the Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2026.".Nov 2
All Wockhardt news releases↗

Follow Wockhardt into a list and get an email when it puts out news.

Follow Wockhardt
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer